Russell L. Basser - Concepedia

Author

Russell L. Basser

CSL (Australia)

Also Known As

, R L Basser, RUSSELL L. BASSER, Russell Basser, Russell L Basser, Russell L. Basser

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

CSL (Australia)The University of Melbourne Murdoch Children's Research Institute The University of Western Australia The Royal Melbourne Hospital

About

Russell L. Basser is an author at CSL (Australia) specializing in medicine, influenza vaccines, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	477
2	Immunology	3	3	251
3	Pathology	2	2	226
4	Cancer Therapeutics	1	1	216
5	Hematology	1	1	10

Russell L. Basser

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Response to a Monovalent 2009 Influenza A (H1N1) Vaccine Michael E. Greenberg, Michael H. Lai, Günter Härtel, New England Journal of Medicine	2009	492
Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor Russell L. Basser, Elizabeth O’Flaherty, Michael Green, Blood	2002	245
Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer Russell L. Basser, John E.J. Rasko, Kerrie Clarke, The Lancet Advanced CancerMalignant DiseaseMedicinePathologyThrombopoietic Effects	1996	216
Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Russell L. Basser, John E.J. Rasko, Kerrie Clarke, PubMed	1997	201
Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children Terry Nolan, Jodie McVernon, Maryanne Skeljo, JAMA	2009	194
A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia Simon He, Samantha J. Busfield, David Ritchie, Leukemia & lymphoma/Leukemia and lymphoma	2014	122
Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX™ vaccine: A phase I study in healthy volunteers Debbie Drane, Eugene Maraskovsky, Rebecca A. Gibson, Human Vaccines	2009	112
High-Dose Chemotherapy With Autologous Stem-Cell Support As Adjuvant Therapy in Breast Cancer: Overview of 15 Randomized Trials Donald A. Berry, Naoto T. Ueno, Marcella M. Johnson, Journal of Clinical Oncology	2011	104
Phase I and Pharmacokinetic Study of Photodynamic Therapy for High-Grade Gliomas Using a Novel Boronated Porphyrin Mark Rosenthal, Bhadu Kavar, John S. Hill, Journal of Clinical Oncology	2001	95
Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children Terry Nolan, Peter Richmond, Neil Formica, Vaccine VaccinationCross-protectionVaccine DevelopmentVaccine TargetImmunology	2008	89

Page 1